Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Coenye, T; Laevens, S; Willems, A; Ohlen, M; Hannant, W; Govan, JRW; Gillis, M; Falsen, E; Vandamme, P
   Burkholderia fungorum sp nov, and Burkholderia caledonica sp nov., two newspecies isolated from the environment, animals and human clinical samples
   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
   
   T. Coenye et al., "Burkholderia fungorum sp nov, and Burkholderia caledonica sp nov., two newspecies isolated from the environment, animals and human clinical samples", INT J SY EV, 51, 2001, pp. 1099-1107
2. Jones, AM; Govan, JRW; Doherty, CJ; Dodd, ME; Isalska, BJ; Stanbridge, TN; Webb, AK
   Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic
   LANCET
   
   A.M. Jones et al., "Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic", LANCET, 358(9281), 2001, pp. 557-558
3. Littlewood, JM; Govan, JRW
   Elusiveness of cystic-fibrosis treatment
   LANCET
   
   J.M. Littlewood e J.R.W. Govan, "Elusiveness of cystic-fibrosis treatment", LANCET, 357(9256), 2001, pp. 633-634
4. Berriatua, E; Ziluaga, I; Miguel-Virto, C; Uribarren, P; Juste, R; Laevens, S; Vandamme, P; Govan, JRW
   Outbreak of subclinical mastitis in a flock of dairy sheep associated withBurkholderia cepacia complex infection
   JOURNAL OF CLINICAL MICROBIOLOGY
   
   E. Berriatua et al., "Outbreak of subclinical mastitis in a flock of dairy sheep associated withBurkholderia cepacia complex infection", J CLIN MICR, 39(3), 2001, pp. 990-994
5. Coenye, T; Vandamme, P; Govan, JRW; Lipuma, JJ
   Taxonomy and identification of the Burkholderia cepacia complex
   JOURNAL OF CLINICAL MICROBIOLOGY
   
   T. Coenye et al., "Taxonomy and identification of the Burkholderia cepacia complex", J CLIN MICR, 39(10), 2001, pp. 3427-3436
6. Simpson, AJ; Wallace, WAH; Marsden, ME; Govan, JRW; Porteous, DJ; Haslett, C; Sallenave, JM
   Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection
   JOURNAL OF IMMUNOLOGY
   
   A.J. Simpson et al., "Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection", J IMMUNOL, 167(3), 2001, pp. 1778-1786
7. Coenye, T; Falsen, E; Hoste, B; Ohlen, M; Goris, J; Govan, JRW; Gillis, M; Vandamme, P
   Description of Pandoraea gen. nov with Pandoraea apista sp nov., Pandoraeapulmonicola sp nov., Pandoraea pnomenusa sp nov., Pandoraea sputorum sp nov and Pandoraea norimbergensis comb. nov.
   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
   
   T. Coenye et al., "Description of Pandoraea gen. nov with Pandoraea apista sp nov., Pandoraeapulmonicola sp nov., Pandoraea pnomenusa sp nov., Pandoraea sputorum sp nov and Pandoraea norimbergensis comb. nov.", INT J SY EV, 50, 2000, pp. 887-899
8. Nzula, S; Vandamme, P; Govan, JRW
   Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosato transducing bacteriophages
   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
   
   S. Nzula et al., "Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosato transducing bacteriophages", FEMS IM MED, 28(4), 2000, pp. 307-312
9. Hutchison, ML; Bonell, EC; Poxton, IR; Govan, JRW
   Endotoxic activity of lipopolysaccharides isolated from emergent potentialcystic fibrosis pathogens
   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
   
   M.L. Hutchison et al., "Endotoxic activity of lipopolysaccharides isolated from emergent potentialcystic fibrosis pathogens", FEMS IM MED, 27(1), 2000, pp. 73-77
10. Hendry, J; Butler, S; Elborn, JS; Govan, JRW; Nelson, J; Shale, DJ; Webb, AK
    Antibody response to Burkholderia cepacia in patients with cystic fibrosiscolonized with Burkholderia cepacia and Pseudomonas aeruginosa
    JOURNAL OF INFECTION
    
    J. Hendry et al., "Antibody response to Burkholderia cepacia in patients with cystic fibrosiscolonized with Burkholderia cepacia and Pseudomonas aeruginosa", J INFECTION, 40(2), 2000, pp. 164-170
11. Govan, JRW
    Infection control in cystic fibrosis: methicillin-resistant Staphylococcusaureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
    
    J.R.W. Govan, "Infection control in cystic fibrosis: methicillin-resistant Staphylococcusaureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex", J ROY S MED, 93, 2000, pp. 40-45
12. Mahenthiralingam, E; Coenye, T; Chung, JW; Speert, DP; Govan, JRW; Taylor, P; Vandamme, P
    Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex
    JOURNAL OF CLINICAL MICROBIOLOGY
    
    E. Mahenthiralingam et al., "Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex", J CLIN MICR, 38(2), 2000, pp. 910-913
13. Hutchison, ML; Govan, JRW
    Pathogenicity of microbes associated with cystic fibrosis
    MICROBES AND INFECTION
    
    M.L. Hutchison e J.R.W. Govan, "Pathogenicity of microbes associated with cystic fibrosis", MICROBES IN, 1(12), 1999, pp. 1005-1014
14. Duncan, SH; Doherty, CJ; Govan, JRW; Neogrady, S; Galfi, P; Stewart, CS
    Characteristics of sheep-rumen isolates of Pseudomonas aeruginosa inhibitory to the growth of Escherichia coli O157
    FEMS MICROBIOLOGY LETTERS
    
    S.H. Duncan et al., "Characteristics of sheep-rumen isolates of Pseudomonas aeruginosa inhibitory to the growth of Escherichia coli O157", FEMS MICROB, 180(2), 1999, pp. 305-310
15. Evans, E; Poxton, IR; Govan, JRW
    Lipopolysaccharide chemotypes of Burkholderia cepacia
    JOURNAL OF MEDICAL MICROBIOLOGY
    
    E. Evans et al., "Lipopolysaccharide chemotypes of Burkholderia cepacia", J MED MICRO, 48(9), 1999, pp. 825-832
16. Coenye, T; Schouls, LM; Govan, JRW; Kersters, K; Vandamme, P
    Identification of Burkholderia species and genomovars from cystic fibrosispatients by AFLP fingerprinting
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY
    
    T. Coenye et al., "Identification of Burkholderia species and genomovars from cystic fibrosispatients by AFLP fingerprinting", INT J SY B, 49, 1999, pp. 1657-1666
17. Coenye, T; Falsen, E; Vancanneyt, M; Hoste, B; Govan, JRW; Kersters, K; Vandamme, P
    Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov.
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY
    
    T. Coenye et al., "Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov.", INT J SY B, 49, 1999, pp. 405-413
18. Coenye, T; Holmes, B; Kersters, K; Govan, JRW; Vandamme, P
    Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al, 1995 and Burkholderia vandii Urakami et al. 1994 are junior synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al 1994 respectively
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY
    
    T. Coenye et al., "Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al, 1995 and Burkholderia vandii Urakami et al. 1994 are junior synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al 1994 respectively", INT J SY B, 49, 1999, pp. 37-42
19. Simpson, AJ; Maxwell, AI; Govan, JRW; Haslett, C; Sallenave, JM
    Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens
    FEBS LETTERS
    
    A.J. Simpson et al., "Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens", FEBS LETTER, 452(3), 1999, pp. 309-313
20. GOVAN JRW; VANDAMME P
    AGRICULTURAL AND MEDICAL MICROBIOLOGY - A TIME FOR BRIDGING GAPS
    Microbiology
    
    J.R.W. Govan e P. Vandamme, "AGRICULTURAL AND MEDICAL MICROBIOLOGY - A TIME FOR BRIDGING GAPS", Microbiology, 144, 1998, pp. 2373-2375
21. DEV D; WALLACE E; SANKARAN R; CUNNIFFE J; GOVAN JRW; WATHEN CG; EMMANUEL FXS
    VALUE OF C-REACTIVE PROTEIN MEASUREMENTS IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    Respiratory medicine
    
    D. Dev et al., "VALUE OF C-REACTIVE PROTEIN MEASUREMENTS IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE", Respiratory medicine, 92(4), 1998, pp. 664-667
22. MORRISON GM; DAVIDSON DJ; KILANOWSKI FM; BORTHWICK DW; CROOK K; MAXWELL AI; GOVAN JRW; DORIN JR
    MOUSE BETA-DEFENSIN-1 IS A FUNCTIONAL HOMOLOG OF HUMAN BETA-DEFENSIN-1
    Mammalian genome
    
    G.M. Morrison et al., "MOUSE BETA-DEFENSIN-1 IS A FUNCTIONAL HOMOLOG OF HUMAN BETA-DEFENSIN-1", Mammalian genome, 9(6), 1998, pp. 453-457
23. LIVESLEY MA; BAXTER IA; LAMBERT PA; GOVAN JRW; WELLER PH; LACEY DE; ALLISON DG; GIWERCMAN B; HOIBY N
    SUBSPECIFIC DIFFERENTIATION OF BURKHOLDERIA-CEPACIA ISOLATES IN CYSTIC-FIBROSIS
    Journal of Medical Microbiology
    
    M.A. Livesley et al., "SUBSPECIFIC DIFFERENTIATION OF BURKHOLDERIA-CEPACIA ISOLATES IN CYSTIC-FIBROSIS", Journal of Medical Microbiology, 47(11), 1998, pp. 999-1006
24. HUTCHISON ML; POXTON IR; GOVAN JRW
    BURKHOLDERIA CEPACIA PRODUCES A HEMOLYSIN THAT IS CAPABLE OF INDUCINGAPOPTOSIS AND DEGRANULATION OF MAMMALIAN PHAGOCYTES
    Infection and immunity
    
    M.L. Hutchison et al., "BURKHOLDERIA CEPACIA PRODUCES A HEMOLYSIN THAT IS CAPABLE OF INDUCINGAPOPTOSIS AND DEGRANULATION OF MAMMALIAN PHAGOCYTES", Infection and immunity, 66(5), 1998, pp. 2033-2039
25. VANDAMME P; HOLMES B; VANCANNEYT M; COENYE T; HOSTE B; COOPMAN R; REVETS H; LAUWERS S; GILLIS M; KERSTERS K; GOVAN JRW
    OCCURRENCE OF MULTIPLE GENOMOVARS OF BURKHOLDERIA-CEPACIA IN CYSTIC-FIBROSIS PATIENTS AND PROPOSAL OF BURKHOLDERIA MULTIVORANS SP. NOV
    International journal of systematic bacteriology
    
    P. Vandamme et al., "OCCURRENCE OF MULTIPLE GENOMOVARS OF BURKHOLDERIA-CEPACIA IN CYSTIC-FIBROSIS PATIENTS AND PROPOSAL OF BURKHOLDERIA MULTIVORANS SP. NOV", International journal of systematic bacteriology, 47(4), 1997, pp. 1188-1200
26. HUGHES JE; STEWART J; BARCLAY GR; GOVAN JRW
    PRIMING OF NEUTROPHIL RESPIRATORY BURST ACTIVITY BY LIPOPOLYSACCHARIDE FROM BURKHOLDERIA-CEPACIA
    Infection and immunity
    
    J.E. Hughes et al., "PRIMING OF NEUTROPHIL RESPIRATORY BURST ACTIVITY BY LIPOPOLYSACCHARIDE FROM BURKHOLDERIA-CEPACIA", Infection and immunity, 65(10), 1997, pp. 4281-4287
27. TATNELL PJ; RUSSELL NJ; GOVAN JRW; GACESA P
    COLONIZATION OF CYSTIC-FIBROSIS PATIENTS BY NON-MUCOID PSEUDOMONAS-AERUGINOSA - CHARACTERIZATION OF THE ALGINATE FROM MUCOID VARIANTS
    Biochemical Society transactions
    
    P.J. Tatnell et al., "COLONIZATION OF CYSTIC-FIBROSIS PATIENTS BY NON-MUCOID PSEUDOMONAS-AERUGINOSA - CHARACTERIZATION OF THE ALGINATE FROM MUCOID VARIANTS", Biochemical Society transactions, 24(3), 1996, pp. 406-406
28. GOVAN JRW; DERETIC V
    MICROBIAL PATHOGENESIS IN CYSTIC-FIBROSIS - MUCOID PSEUDOMONAS-AERUGINOSA AND BURKHOLDERIA-CEPACIA
    Microbiological reviews
    
    J.R.W. Govan e V. Deretic, "MICROBIAL PATHOGENESIS IN CYSTIC-FIBROSIS - MUCOID PSEUDOMONAS-AERUGINOSA AND BURKHOLDERIA-CEPACIA", Microbiological reviews, 60(3), 1996, pp. 539
29. CHENG K; SMYTH RL; GOVAN JRW; DOHERTY C; WINSTANLEY C; DENNING N; HEAF DP; VANSAENE H; HART CA
    SPREAD OF BETA-LACTAM-RESISTANT PSEUDOMONAS-AERUGINOSA IN A CYSTIC-FIBROSIS CLINIC
    Lancet
    
    K. Cheng et al., "SPREAD OF BETA-LACTAM-RESISTANT PSEUDOMONAS-AERUGINOSA IN A CYSTIC-FIBROSIS CLINIC", Lancet, 348(9028), 1996, pp. 639-642
30. GOVAN JRW; HUGHES JE; VANDAMME P
    BURKHOLDERIA CEPACIA - MEDICAL, TAXONOMIC AND ECOLOGICAL ISSUES
    Journal of Medical Microbiology
    
    J.R.W. Govan et al., "BURKHOLDERIA CEPACIA - MEDICAL, TAXONOMIC AND ECOLOGICAL ISSUES", Journal of Medical Microbiology, 45(6), 1996, pp. 395-407
31. SHAW D; POXTON IR; GOVAN JRW
    BIOLOGICAL-ACTIVITY OF BURKHOLDERIA (PSEUDOMONAS) CEPACIA LIPOPOLYSACCHARIDE
    FEMS immunology and medical microbiology
    
    D. Shaw et al., "BIOLOGICAL-ACTIVITY OF BURKHOLDERIA (PSEUDOMONAS) CEPACIA LIPOPOLYSACCHARIDE", FEMS immunology and medical microbiology, 11(2), 1995, pp. 99-106
32. SIMPSON IN; HUNTER R; GOVAN JRW
    ARE ALL CARBAPENEMS CREATED EQUAL
    Journal of antimicrobial chemotherapy
    
    I.N. Simpson et al., "ARE ALL CARBAPENEMS CREATED EQUAL", Journal of antimicrobial chemotherapy, 35(5), 1995, pp. 707-708
33. BUTLER SL; DOHERTY CJ; HUGHES JE; NELSON JW; GOVAN JRW
    BURKHOLDERIA CEPACIA AND CYSTIC-FIBROSIS - DO NATURAL ENVIRONMENTS PRESENT A POTENTIAL HAZARD
    Journal of clinical microbiology
    
    S.L. Butler et al., "BURKHOLDERIA CEPACIA AND CYSTIC-FIBROSIS - DO NATURAL ENVIRONMENTS PRESENT A POTENTIAL HAZARD", Journal of clinical microbiology, 33(4), 1995, pp. 1001-1004
34. GOVAN JRW
    BURKHOLDERIA CEPACIA IN CYSTIC-FIBROSIS
    The New England journal of medicine
    
    J.R.W. Govan, "BURKHOLDERIA CEPACIA IN CYSTIC-FIBROSIS", The New England journal of medicine, 332(12), 1995, pp. 819-820
35. BUTLER SL; NELSON JW; POXTON IR; GOVAN JRW
    SERUM SENSITIVITY OF BURKHOLDERIA (PSEUDOMONAS) CEPACIA ISOLATES FROMPATIENTS WITH CYSTIC-FIBROSIS
    FEMS immunology and medical microbiology
    
    S.L. Butler et al., "SERUM SENSITIVITY OF BURKHOLDERIA (PSEUDOMONAS) CEPACIA ISOLATES FROMPATIENTS WITH CYSTIC-FIBROSIS", FEMS immunology and medical microbiology, 8(4), 1994, pp. 285-292
36. NELSON JW; BUTLER SL; KRIEG D; GOVAN JRW
    VIRULENCE FACTORS OF BURKHOLDERIA-CEPACIA
    FEMS immunology and medical microbiology
    
    J.W. Nelson et al., "VIRULENCE FACTORS OF BURKHOLDERIA-CEPACIA", FEMS immunology and medical microbiology, 8(2), 1994, pp. 89-97
37. SIMPSON IN; FINLAY J; WINSTANLEY DJ; DEWHURST N; NELSON JW; BUTLER SL; GOVAN JRW
    MULTI-RESISTANCE ISOLATES POSSESSING CHARACTERISTICS OF BOTH BURKHOLDERIA-(PSEUDOMONAS)-CEPACIA AND BURKHOLDERIA-GLADIOLI FROM PATIENTS WITH CYSTIC-FIBROSIS
    Journal of antimicrobial chemotherapy
    
    I.N. Simpson et al., "MULTI-RESISTANCE ISOLATES POSSESSING CHARACTERISTICS OF BOTH BURKHOLDERIA-(PSEUDOMONAS)-CEPACIA AND BURKHOLDERIA-GLADIOLI FROM PATIENTS WITH CYSTIC-FIBROSIS", Journal of antimicrobial chemotherapy, 34(3), 1994, pp. 353-361
38. SIMPSON IN; HUNTER R; GOVAN JRW; NELSON JW
    DO ALL PSEUDOMONAS-CEPACIA PRODUCE CARBAPENEMASES
    Journal of antimicrobial chemotherapy
    
    I.N. Simpson et al., "DO ALL PSEUDOMONAS-CEPACIA PRODUCE CARBAPENEMASES", Journal of antimicrobial chemotherapy, 32(2), 1993, pp. 339-341
39. GOVAN JRW; NELSON JW
    MICROBIOLOGY OF CYSTIC-FIBROSIS LUNG INFECTIONS - THEMES AND ISSUES
    Journal of the Royal Society of Medicine
    
    J.R.W. Govan e J.W. Nelson, "MICROBIOLOGY OF CYSTIC-FIBROSIS LUNG INFECTIONS - THEMES AND ISSUES", Journal of the Royal Society of Medicine, 86, 1993, pp. 11-18
40. GOVAN JRW; BROWN PH; MADDISON J; DOHERTY CJ; NELSON JW; DODD M; GREENING AP; WEBB AK
    EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT INCYSTIC-FIBROSIS
    Lancet
    
    J.R.W. Govan et al., "EVIDENCE FOR TRANSMISSION OF PSEUDOMONAS-CEPACIA BY SOCIAL CONTACT INCYSTIC-FIBROSIS", Lancet, 342(8862), 1993, pp. 15-19
41. MARTIN DW; SCHURR MJ; MUDD MH; GOVAN JRW; HOLLOWAY BW; DERETIC V
    MECHANISM OF CONVERSION TO MUCOIDY IN PSEUDOMONAS-AERUGINOSA INFECTING CYSTIC-FIBROSIS PATIENTS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    D.W. Martin et al., "MECHANISM OF CONVERSION TO MUCOIDY IN PSEUDOMONAS-AERUGINOSA INFECTING CYSTIC-FIBROSIS PATIENTS", Proceedings of the National Academy of Sciences of the United Statesof America, 90(18), 1993, pp. 8377-8381
42. NELSON JW; BUTLER SL; BROWN PH; GREENING AP; GOVAN JRW
    SERUM IGG AND SPUTUM IGA ANTIBODY TO CORE LIPOPOLYSACCHARIDE ANTIGEN FROM PSEUDOMONAS-CEPACIA IN PATIENTS WITH CYSTIC-FIBROSIS
    Journal of Medical Microbiology
    
    J.W. Nelson et al., "SERUM IGG AND SPUTUM IGA ANTIBODY TO CORE LIPOPOLYSACCHARIDE ANTIGEN FROM PSEUDOMONAS-CEPACIA IN PATIENTS WITH CYSTIC-FIBROSIS", Journal of Medical Microbiology, 39(1), 1993, pp. 39-47